Clinical TrialsMesothelioma Clinical Trials 2022
Reviewed by Michael Gill, B. Sc.
Image of University of California Los Angeles Medical Center in Los Angeles, United States.
Phase-Based Progress Estimates
1
Effectiveness
1
Safety

PRO1184for erbB-2 Receptor

18+
All Sexes
This study will test the safety, including side effects, and determine the characteristics of a drug called PRO1184 in participants with solid tumors. Participants will have solid tumor cancer that has spread through the body (metastatic) or cannot be removed with surgery (unresectable). This study will have two parts. Part A of the study will find out how much and how frequently PRO1184 should be given to participants. Part B will use the dose and schedule found in Part A to find out how safe PRO1184 is and if it works to treat solid tumor cancers.
Phase 1 & 2
Recruiting
University of California Los Angeles Medical Center (+9 Sites)ProfoundBio US Co.
25 Mesothelioma Clinical Trials Near Me
Top Hospitals for Mesothelioma Clinical Trials
Image of MD Anderson Cancer Center in Texas.
MD Anderson Cancer Center
Houston
7Active Trials
9All Time Trials for Mesothelioma
2007First Mesothelioma Trial
Top Cities for Mesothelioma Clinical Trials
Mesothelioma Clinical Trials by Phase of Trial
Phase < 1 Mesothelioma Clinical Trials
2Active Mesothelioma Clinical Trials
2Number of Unique Treatments
3Number of Active Locations
Healthy ParticipantsHyperthermic Intraperitoneal Chemotherapy
Mesothelioma Clinical Trials by Age Group
18+ Mesothelioma Clinical Trials
95Active Mesothelioma Clinical Trials
TC-510APG-5918NGM438MRTX1719HFB200301NGM831TAK-500IAG933
Most Recent Mesothelioma Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
LMB-100 for Epithelial Tumors, Malignant
11/29/2022
Phase 1
PRO1184 for erbB-2 Receptor
11/28/2022
Phase 1 & 2
Pembrolizumab for Mesothelioma, Malignant
10/28/2022
Phase 1
APG-5918 for Mesothelioma
9/30/2022
Phase 1
AMXT1501 for Carcinoma, Papillary
8/8/2022
Phase 1 & 2
Top Treatments for Mesothelioma Clinical Trials
Treatment Name
Active Mesothelioma Clinical Trials
All Time Trials for Mesothelioma
First Recorded Mesothelioma Trial
Pembrolizumab
5
24
2015
Nivolumab
4
11
2015
Tazemetostat
2
3
2016
pembrolizumab
2
3
2015
LMB-100
2
6
2016
Recently Completed Studies with FDA Approved Treatments for Mesothelioma
Treatment
Year
Sponsor
Magnesium Sulfate
2021
Dana-Farber Cancer Institute
Bosutinib
2019
Nagla Abdel Karim
nanoliposomal irinotecan
2019
Stony Brook University
BAY2287411
2018
Bayer
ADI-PEG 20 plus Pem Cis
2017
Polaris Group
MEDI4736
2016
Baylor College of Medicine
Alisertib
2015
M.D. Anderson Cancer Center
Dasatinib
2008
M.D. Anderson Cancer Center

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 6th, 2021

Last Reviewed: October 19th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.